2014
DOI: 10.1158/1055-9965.epi-13-0962
|View full text |Cite
|
Sign up to set email alerts
|

Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer

Abstract: Survival in epithelial ovarian cancer (EOC) is influenced by the host immune response, yet the key genetic determinants of inflammation and immunity that impact prognosis are not known. The nuclear factor-kappa B (NF-κB) transcription factor family plays an important role in many immune and inflammatory responses, including the response to cancer. We studied common inherited variation in 210 genes in the NF-κB family in 10,084 patients with invasive EOC (5,248 high grade serous, 1,452 endometrioid, 795 clear c… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
12
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 26 publications
0
12
0
Order By: Relevance
“…CARD11 might interact with the pro-apoptotic protein Bcl-10, and CARD11 overexpression may enhance NF-κB activation [46]. In addition, oncogenic mutations in CARD11 are reportedly related to several types of lymphoma progression [31], and CARD11 expression in leukocytes suggests that it might influence immune/inflammatory responses to epithelial ovarian cancer [44]. Thus, we conclude that suppression of CARD11 suppresses proliferation and invasion and facilitates apoptosis of glioma cells via the NF-κB pathway.…”
Section: Discussionmentioning
confidence: 78%
See 1 more Smart Citation
“…CARD11 might interact with the pro-apoptotic protein Bcl-10, and CARD11 overexpression may enhance NF-κB activation [46]. In addition, oncogenic mutations in CARD11 are reportedly related to several types of lymphoma progression [31], and CARD11 expression in leukocytes suggests that it might influence immune/inflammatory responses to epithelial ovarian cancer [44]. Thus, we conclude that suppression of CARD11 suppresses proliferation and invasion and facilitates apoptosis of glioma cells via the NF-κB pathway.…”
Section: Discussionmentioning
confidence: 78%
“…Furthermore, NF-κB is involved in prostatic disease progression (neoplasic and inflammatory) [42], and it has been shown that the oncogenic risk of constitutive NF-κB activation due to germline CARD11 gain-of-function (GOF) mutations might elevate B-cell malignancy resulting from a larger number of naïve B cells [43]. The NF-κB transcription factor family has great effects on many inflammatory and immune responses, including the response to cancer [44]. Although the specific mechanism of lncRNAs is well understood, most lncRNAs exert their biological function via interaction with other molecules [45], such as microRNAs, other lncRNAs, genomic DNA, and, in particular, proteins involved in vital pathways such as NF-κB signaling [45].…”
Section: Discussionmentioning
confidence: 99%
“…TRAF2 (TNF receptor-associated factor 2) regulates activation of NF-kappa-B and JNK and is involved in apoptosis. Genetic polymorphisms in this gene have been associated with high-grade serous ovarian cancer and patients with clear cell ovarian carcinoma 18 . NID2 (Nidogen-2) has been proposed as blood biomarker for ovarian cancer and is strongly correlated to CA125 levels 19 .…”
Section: Discussionmentioning
confidence: 99%
“…NF-κB, a pleiotropic transcription factor, plays important roles in pathological processes associated with cancer development, such as proliferation, migration, invasion, angiogenesis, drug resistance and inflammation (21)(22)(23). It was also found in previous studies that the induction of EMT was closely associated with the activation of NF-κB.…”
Section: Discussionmentioning
confidence: 99%